Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
SUPPRESSION OF IN-VITRO TYPE-1...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
Bibliographic Details
Main Authors:
De Wit, J
,
Al-Mossawi, M
,
Huhn, M
,
Arancibia, C
,
Powrie, F
,
Bowness, P
Format:
Journal article
Published:
2014
Holdings
Description
Similar Items
Staff View
Similar Items
RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease.
by: de Wit, J, et al.
Published: (2015)
BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
by: Hammitzsch, A, et al.
Published: (2014)
Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
by: Xiao, Sheng, et al.
Published: (2017)
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
by: Amineh Ghaderi, et al.
Published: (2020-06-01)
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
by: Hammitzsch, A, et al.
Published: (2015)